ZAFRILLA cpr 2 mg 6 x 14 pce
7680685870025
CH-68587
G03DB08
09.99.0.
1 / 3
google
Details
- Product number
- 6858701
- CPT
- -
- Packaging group
- 6 x 14
- Unit
- Tablette(n)
- Composition
- dienogestum 2.00 mg, lactosum monohydricum 62.80 mg, amylum pregelificatum, cellulosum microcristallinum, povidonum K 25, crospovidonum, talcum, magnesii stearas, pro compresso.
Articles (1)
Zafrilla 2 mg, Tabletten
Tabletten
6 x 14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
62.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 126.20
Specialties list
Yes
Generic
Yes
SL addition date:
01/02/2023
Authorization holder
Gedeon Richter (Schweiz) AG
1202 Genève
Authorization information
- Swissmedic authorization number
- 68587
- Drug name
- Zafrilla, Tabletten
- Galenic form
- FILM
- ATC Code
- G03DB08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/09/2022
- Authorization expiration date
- 04/09/2027
- IT number
- 09.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZAFRILLA cpr 2 mg 6 x 14 pce
- Description (DE)
- ZAFRILLA Tabl 2 mg 6 x 14 Stk
- Market launch
- 05/09/2022
- Narcotic (BTM)
- No